f.ibarra

TL2 · Plovdiv

Contributes reviews on supplier material. Based in Plovdiv.

Joined 1 May 2025 · last posted 1d

84 posts, newest first. Showing up to 150.

Prior authorisation: what the criteria usually require — a second dataset Replied, post #73 · Access › Insurance & coverage · 27 Jul 2026 · 15 likes Prior authorisation criteria are usually published by the payer, and reading them before the appointment changes the outcome more than anything else does.
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #56 · Pharmacology › Receptor biology · 26 Jul 2026 · 1 like Receptor desensitisation and internalisation are real phenomena in vitro and their clinical relevance to these compounds is not established. That distinction gets lost…
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #50 · Documentation › Doc review · 26 Jul 2026 · 2 likes The most useful reply I ever got about draft on reconstitution arithmetic was a request to state my units. It sounds like pedantry and it has saved me twice.
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #121 · Compounds › Semaglutide · 25 Jul 2026 · 4 likes Worth separating semaglutide and gastric emptying as a question about the compound from semaglutide and gastric emptying as a question about the documentation. They get…
Transit times by route, from a logged dataset Replied, post #25 · Sourcing › Logistics · 22 Jul 2026 · 4 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #99 · Analytics › Method validation · 21 Jul 2026 · 3 likes On post #96 — agreed on the reasoning, with one qualification. Two things can be true about Specificity at once: the mechanism is plausible and the evidence for the…
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one Replied, post #8 · Compounds › Oral incretins · 19 Jul 2026 · 15 likes Following this. I have the same question and no better information than the first post.
What a reversed-phase purity number actually is Replied, post #69 · Analytics › HPLC & UHPLC · 19 Jul 2026 · 11 likes Post #67 describes the usual case. This is about the unusual one. I have been on both sides of the reversed-phase purity number argument in this category within…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #14 · Clinical › Prescriber conversations · 18 Jul 2026 · 3 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
What published stability data actually covers, and what it does not Replied, post #11 · Practice › Storage & stability · 15 Jul 2026 · 0 likes I had written a reply contradicting post #7 and deleted it. Here is what survived. I changed my mind about published stability data actually covers after someone here…
What to bring: records that a clinician can actually use — a second dataset Replied, post #34 · Clinical › Prescriber conversations · 14 Jul 2026 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation. Written in the hope of being…
Priming a pen and whether the primed volume is wasted Replied, post #5 · Devices › Pens & autoinjectors · 14 Jul 2026 · 23 likes Everything in the opening post holds. The case it does not cover is the one I have. A pen that has been dropped may not be visibly damaged and may not deliver…
Ultrasound and skinfolds: operator dependence in practice Replied, post #51 · Outcomes › Body composition · 10 Jul 2026 · 0 likes Neither method is capable of detecting the month-to-month changes that people report detecting month to month. I looked this up rather than remembered it, which is the…
Common supplements people ask about, assessed one at a time Replied, post #11 · Practice › Interactions · 5 Jul 2026 · 3 likes Quietly grateful for the plain phrasing. Not every thread gets that.
Cleaning a self-reported dataset and what you throw away Replied, post #2 · Data & Tools › Datasets · 2 Jul 2026 · 9 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
A supplier who responds to a discrepancy with silence — what changed since Replied, post #73 · Sourcing › Red flags · 1 Jul 2026 · 6 likes Where I would push back on the supplier consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #82 · Compounds › Repair & healing peptides · 1 Jul 2026 · 0 likes An honest declaration on Stability of BPC-157: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
Alcohol: what is documented and what is folklore Replied, post #75 · Practice › Interactions · 24 Jun 2026 · 9 likes Worth separating two things that post #71 runs together. I read the earlier replies on alcohol twice before writing this, because I had assumed the opposite and wanted…
Coming back to: Why I now write the concentration on the vial in marker Replied, post #10 · Practice › Reconstitution · 23 Jun 2026 · 0 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
Run-in periods and the population they select Replied, post #139 · Evidence › Trials · 18 Jun 2026 · 9 likes Fair, and the limits you put on it are the part I will remember.
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #52 · Practice › Administration · 8 Jun 2026 · 3 likes Thank you for taking the time. That was more work than a reply usually is.
A critique that turned out to be unfair, retracted by its author Replied, post #3 · Evidence › Study critique · 25 May 2026 · 1 like Confirming the opening post from a second method, which matters more than confirming it from a second person. Where a critique rests on a subgroup, check whether the…
Drawing up with one needle and injecting with another Replied, post #3 · Practice › Administration · 9 May 2026 · 5 likes Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety degrees and a longer one at forty-five put the material in…
The headache that turns out to be dehydration — the long version Replied, post #27 · Nutrition & Training › Hydration & electrolytes · 27 Apr 2026 · 7 likes The most useful reply I ever got about headache was a request to state my units. It sounds like pedantry and it has saved me twice.
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #19 · Safety › Contraindications · 24 Apr 2026 · 1 like Worth separating two things that post #17 runs together. Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same…
Why chargeback is not the safety net people assume Replied, post #9 · Sourcing › Payments · 16 Apr 2026 · 11 likes I have no financial interest in anything named in this thread and I want to say so before I comment on chargeback, because it is the sort of subject where it matters.
Coming back to: Half-life, steady state, and accumulation worked through Replied, post #17 · Pharmacology › Pharmacokinetics · 15 Apr 2026 · 0 likes Adding a reference point for Half-life. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately.
List price versus negotiated price versus what you pay Replied, post #40 · Access › Pricing · 11 Apr 2026 · 0 likes Picking up post #38: that is the part I would want checked first. List price versus negotiated price has been discussed here with more heat than it deserves, mostly…
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #27 · Evidence › Journal club · 9 Apr 2026 · 0 likes I had written a reply contradicting post #25 and deleted it. Here is what survived. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could…
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #67 · Sourcing › Logistics · 2 Apr 2026 · 12 likes Peak periods and public holidays affect this more than any other factor and are entirely predictable in advance.
Five questions in one post gets you one answer — how to split them Replied, post #36 · Start Here › How to Ask · 21 Mar 2026 · 31 likes Narrowing post #33, because the general version has more than one answer. Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable…
[2026 update] Distinguishing expected GI effects from something that needs urgent… Replied, post #5 · Practice › Side effects · 14 Mar 2026 · 16 likes Taking post #2 at face value and following it one step further. Reflux and eructation are the two most under-reported effects in the first-hand accounts here, and both…
What a certificate commits its issuer to — one year on Replied, post #27 · Analytics › COA interpretation · 5 Mar 2026 · 0 likes Reading rather than answering, but this is the post I would point somebody at.
Contributing data without breaching anyone's privacy Replied, post #33 · Data & Tools › Datasets · 4 Mar 2026 · 6 likes Reproducibility: if sharing data, include enough context (compound, dose, timeframe, method) that someone reading it understands what it represents.
Measurement error in a self-reported exposure Replied, post #130 · Evidence › Study critique · 28 Feb 2026 · 0 likes Building on post #127 rather than restating it. Statistical significance and clinical importance are different and both are needed. A significant difference below the…
Foaming during reconstitution and whether it matters — the long version Replied, post #47 · Practice › Reconstitution · 27 Feb 2026 · 2 likes This is the answer, and the reason it is the answer is the more useful part.
Residual solvents and scavengers: what is looked for — what changed since Replied, post #3 · Analytics › Impurities & related substances · 28 Jan 2026 · 11 likes Everything in the opening post holds. The case it does not cover is the one I have. Trifluoroacetate is a counter-ion rather than an impurity, and it appears in the…
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #26 · Clinical › Special populations · 22 Jan 2026 · 4 likes Dedicated trials in under-studied populations are the only real remedy and several are ongoing, which is worth saying rather than speculating.
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #3 · Evidence › Trials · 2 Jan 2026 · 0 likes Taking post #2 at face value and following it one step further. I have no financial interest in anything named in this thread and I want to say so before I comment on…
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #18 · Compounds › Oral incretins · 30 Dec 2025 · 15 likes This follows post #15 rather than contradicting it. Dose equivalence between oral and injectable formulations is not a simple conversion and no published factor should…
Research-use-only labelling: what it means and what it does not Replied, post #79 · Sourcing › Regulatory · 28 Dec 2025 · 8 likes Post #76 put the caveat in the right place and I want to underline it. An observation about research-use-only labelling that I cannot explain and am posting anyway, on…
Gastro-oesophageal reflux: improving or worsening? Replied, post #7 · Clinical › Comorbidities · 26 Dec 2025 · 8 likes Nothing to add, except that this is the answer I would give if asked.
Second pass at: Metformin co-administration and additive GI effects Replied, post #17 · Practice › Interactions · 12 Dec 2025 · 0 likes I read post #15 twice before replying, because I had assumed the opposite. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular…
Prescription requirements and telehealth models Replied, post #40 · Sourcing › Regulatory · 30 Nov 2025 · 23 likes Coming back to post #38, because the follow-up matters more than the original answer. If you can confirm or contradict a position for your own region, please date the…
Pen dose counters: what a click does and does not guarantee Replied, post #67 · Devices › Pens & autoinjectors · 17 Nov 2025 · 7 likes Post #64 is the version of this I will quote in future. One addition. Research-use-only material does not come in a metering device, and adapting one is neither…
[2026 update] What steady state means for the decision to escalate Replied, post #26 · Practice › Dosing & titration · 7 Nov 2025 · 0 likes Adding the boring version of steady state, because the interesting version keeps getting posted and the boring one is usually right. Check the ordinary explanations, in…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #151 · Practice › Reconstitution · 24 Oct 2025 · 0 likes On post #147 — agreed on the reasoning, with one qualification. How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume…
Payment mechanics and the recovery options that do not exist Replied, post #5 · Sourcing › Payments · 18 Oct 2025 · 0 likes Answering the question the opening post raises rather than the one it answers. Recurring billing: if a supplier sets up recurring billing by default, understanding the…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #60 · Documentation › Doc review · 19 Sep 2025 · 18 likes Taking post #59 at face value and following it one step further. The number people quote for Promotion criteria is a central estimate presented without its interval,…
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #107 · Compounds › Secretagogues & GH axis · 28 Aug 2025 · 26 likes Post #106 is the version of this I will quote in future. One addition. Effects reported at the level of appetite are the most consistently described and the most…
Coming back to: Sample size calculations, read backwards from the published number Replied, post #79 · Evidence › Trials · 23 Aug 2025 · 24 likes Sample size calculations sits at the boundary between what this community can usefully discuss and what it cannot, and I think it falls on the discussable side, narrowly.
Coming back to: Official shortage notices and what they authorise Replied, post #90 · Access › Shortages · 15 Aug 2025 · 0 likes Source for the Official shortage notices figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is…
Substitution between formats during a shortage Replied, post #29 · Access › Shortages · 27 Jul 2025 · 26 likes The arithmetic in post #28 is right; the assumption feeding it is the part to check. The strongest argument against my own position on substitution between formats,…
Counter-ion content and its effect on measured mass Replied, post #94 · Analytics › Mass spectrometry · 17 Jul 2025 · 30 likes Post #91 is right about the mechanism and I think understates the practical bit. Counter-ion content looks different depending on whether you are reading the primary…
A side-effect grading scheme this community uses, and its limits Replied, post #6 · Practice › Side effects · 15 Jul 2025 · 2 likes Coming back to post #2, because the follow-up matters more than the original answer. I think the side-effect grading scheme question is answerable and has not been…
[2026 update] Gastro-oesophageal reflux: improving or worsening? Replied, post #2 · Clinical › Comorbidities · 12 Jun 2025 · 10 likes Adding a reference point for Gastro-oesophageal reflux. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
Reading a regulatory notice rather than an article about it — what changed since Replied, post #15 · Sourcing › Regulatory · 7 Jun 2025 · 7 likes Date every claim in this subcategory. A regulatory position stated without a date is worse than no claim, because it will be read as current indefinitely.
Follow-up: What other technical communities get right that we do not Replied, post #115 · Lounge › Off topic · 31 May 2025 · 1 like Adjacent and interesting: you might post something about nutrition, bioavailability from a food perspective, or the sociology of weight. Adjacent to this community's…
Second pass at: Semaglutide and alcohol: what is actually documented Replied, post #4 · Compounds › Semaglutide · 19 May 2025 · 12 likes Acknowledging rather than arguing. The reasoning holds as far as I can follow it.
Coming back to: What published stability data actually covers, and what it does not Replied, post #43 · Practice › Storage & stability · 17 May 2025 · 15 likes Everything in post #41 holds. The case it does not cover is the one I have. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #96 · Practice › Reconstitution · 3 May 2025 · 1 like Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
Cost per milligram, computed honestly across formats — the long version Replied, post #62 · Access › Pricing · 11 Apr 2025 · 0 likes The arithmetic in post #61 is right; the assumption feeding it is the part to check. Nothing here is financial advice and none of it is a route to a transaction.
Coverage for the indication versus for the drug Replied, post #26 · Access › Insurance & coverage · 11 Apr 2025 · 19 likes Reading rather than answering, but this is the post I would point somebody at.
An emergency department visit, described afterwards Replied, post #5 · Safety › Adverse events · 20 Mar 2025 · 0 likes Two claims get bundled together under emergency department visit and they need separating. The descriptive one — this is what was observed — is usually well supported.…
About the Red flags category Replied, post #5 · Sourcing › Red flags · 6 Mar 2025 · 4 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #79 · Access › International · 5 Mar 2025 · 4 likes Post #76 describes the usual case. This is about the unusual one. I would keep Cross-border purchase within and the decision it usually gets used for separate in this…
Pharmaceutical compounding rules, summarised from primary sources Replied, post #87 · Sourcing › Regulatory · 3 Mar 2025 · 13 likes Coming back to post #85, because the follow-up matters more than the original answer. Import rules for personal quantities differ from commercial import rules and both…
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #17 · Sourcing › Independent verification · 25 Feb 2025 · 0 likes The lot identifier has to match across vial, certificate and invoice for any of this to mean anything. It is the floor and it is worth checking every time.
Validating a method you did not develop — does this still hold? Replied, post #19 · Analytics › Method validation · 17 Feb 2025 · 1 like Adding a data point of agreement rather than a data point.
Reading order for a first week here, and what to skip until later Replied, post #4 · Start Here › Welcome · 13 Feb 2025 · 0 likes Where I would push back on the reading order consensus is the confidence, not the direction. The direction looks right. The confidence is borrowed.
Why mass spectrometry cannot tell you about an epimer Replied, post #56 · Analytics › Mass spectrometry · 13 Feb 2025 · 0 likes On post #52 — agreed on the reasoning, with one qualification. Combining a chromatographic result with a mass result is genuinely orthogonal confirmation. Either alone…
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #114 · Compounds › Oral incretins · 28 Dec 2024 · 7 likes Post #111 is right about the mechanism and I think understates the practical bit. Taking the oral product with more water than instructed reduces absorption rather than…
Oxidation pathways for methionine and tryptophan Replied, post #17 · Analytics › Impurities & related substances · 26 Dec 2024 · 23 likes I had written a reply contradicting post #13 and deleted it. Here is what survived. Where I would push back on the oxidation pathways for methionine consensus is the…
Fixed versus detachable needles: the trade-offs Replied, post #70 · Devices › Syringes & needles · 25 Dec 2024 · 14 likes Answering the question post #68 raises rather than the one it answers. The claim about fixed versus detachable needles upthread is stronger than its source supports. I…
[2026 update] EU-wide position versus national implementation Started this topic · Regional › European Union · 19 Dec 2024 · 46 likes On the subject in the title: EU-wide position versus national implementation Working notes rather than a conclusion. A methods question rather than a substantive one,…
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #14 · Compounds › Repair & healing peptides · 8 Dec 2024 · 7 likes Bookmarking this. I will come back when I have something worth adding.
Washout with a one-week half-life: the arithmetic Replied, post #78 · Research Methods › N-of-1 designs · 6 Dec 2024 · 0 likes Objective versus subjective measures: subjective measures (how you feel) are vulnerable to bias. Objective measures (weight, strength on a specific exercise) are less…
Reading a supplementary appendix and finding the interesting part Replied, post #32 · Evidence › Trials · 27 Nov 2024 · 0 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #56 · Compounds › Tirzepatide · 26 Nov 2024 · 5 likes I had written a reply contradicting post #52 and deleted it. Here is what survived. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per…
What we do not know about retatrutide, listed explicitly Replied, post #4 · Compounds › Retatrutide · 24 Nov 2024 · 18 likes That is the distinction I keep failing to hold on to. Written down now.
Second pass at: Retatrutide dose escalation in the published trials Replied, post #99 · Compounds › Retatrutide · 23 Jul 2024 · 26 likes Building on post #96 rather than restating it. Genuine question rather than a rhetorical one: has anyone here actually observed Retatrutide dose escalation, as opposed…
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #8 · Nutrition & Training › Hydration & electrolytes · 21 Jul 2024 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
The mass-error checker and its intended scope Replied, post #116 · Data & Tools › Calculators · 12 Jul 2024 · 2 likes Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than others and is worth stating either way. That has held every…
Assessing a warm arrival: the decision process — one year on Replied, post #50 · Sourcing › Logistics · 30 May 2024 · 4 likes Saving this. It is the version I will quote when the question comes round again.